Susquehanna International Group, LLP Compugen LTD Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Compugen LTD stock. As of the latest transaction made, Susquehanna International Group, LLP holds 68,300 shares of CGEN stock, worth $109,280. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,300

Previous 116,700 41.47%

Holding current value

$109,280

Previous $196,000 37.24%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$1.75 - $2.95 $71,886 - $121,180	-41,078 Reduced 27.25%	109,662 $282,000
Q4 2023 Feb 14, 2024	BUY	$0.53 - $2.0 $79,892 - $301,480	150,740 New	150,740 $298,000
Q2 2023 Aug 11, 2023	BUY	$0.57 - $1.38 $1,186 - $2,871	2,081 Added 12.46%	18,781 $21,000
Q1 2023 May 16, 2023	BUY	$0.68 - $1.11 $11 - $18	17 Added 0.1%	16,700 $11,000
Q4 2022 Feb 14, 2023	BUY	$0.58 - $1.2 $9,676 - $20,019	16,683 New	16,683 $12,000
Q2 2022 Aug 15, 2022	BUY	$1.57 - $3.33 $51,411 - $109,044	32,746 Added 114.32%	61,391 $114,000
Q1 2022 May 16, 2022	SELL	$2.76 - $4.64 $806,954 - $1.36 Million	-292,375 Reduced 91.08%	28,645 $92,000
Q4 2021 Feb 14, 2022	SELL	$4.09 - $7.16 $39,996 - $70,017	-9,779 Reduced 2.96%	321,020 $1.38 Million
Q3 2021 Nov 15, 2021	SELL	$5.8 - $8.02 $10,869 - $15,029	-1,874 Reduced 0.56%	330,799 $1.98 Million
Q2 2021 Aug 11, 2021	BUY	$6.87 - $9.16 $274,058 - $365,410	39,892 Added 13.63%	332,673 $2.76 Million
Q1 2021 May 17, 2021	BUY	$7.67 - $13.77 $532,436 - $955,885	69,418 Added 31.08%	292,781 $2.52 Million
Q4 2020 Feb 16, 2021	SELL	$12.07 - $17.95 $923,210 - $1.37 Million	-76,488 Reduced 25.51%	223,363 $2.71 Million
Q3 2020 Nov 16, 2020	BUY	$14.16 - $19.45 $1.21 Million - $1.66 Million	85,101 Added 39.63%	299,851 $4.87 Million
Q2 2020 Aug 14, 2020	BUY	$6.97 - $17.12 $1.16 Million - $2.84 Million	166,074 Added 341.18%	214,750 $3.23 Million
Q1 2020 May 15, 2020	SELL	$5.79 - $11.83 $70,765 - $144,586	-12,222 Reduced 20.07%	48,676 $354,000
Q4 2019 Feb 14, 2020	BUY	$3.9 - $6.16 $29,062 - $45,904	7,452 Added 13.94%	60,898 $363,000
Q3 2019 Nov 14, 2019	SELL	$3.01 - $4.49 $77,682 - $115,877	-25,808 Reduced 32.56%	53,446 $226,000
Q2 2019 Aug 16, 2019	BUY	$2.8 - $4.14 $26,014 - $38,464	9,291 Added 13.28%	79,254 $304,000
Q2 2019 Aug 14, 2019	BUY	$2.8 - $4.14 $58,189 - $86,037	20,782 Added 42.26%	69,963 $269,000
Q1 2019 May 15, 2019	SELL	$2.35 - $4.19 $137,209 - $244,641	-58,387 Reduced 54.28%	49,181 $204,000
Q4 2018 Feb 14, 2019	BUY	$2.17 - $3.8 $233,422 - $408,758	107,568 New	107,568 $233,000
Q3 2018 Nov 14, 2018	SELL	$3.0 - $4.05 $200,523 - $270,706	-66,841 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$3.15 - $4.7 $70,040 - $104,504	-22,235 Reduced 24.96%	66,841 $221,000
Q1 2018 May 15, 2018	BUY	$2.5 - $4.45 $222,690 - $396,388	89,076 New	89,076 $396,000

Others Institutions Holding CGEN

# of Institutions

Shares Held

13.1M

Call Options Held

79.2K

Put Options Held

12.7K

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $139M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Compugen LTD Transaction History